文献速递神经肿瘤

遗传祖先超级人群在儿童中枢神经系统肿瘤中显示不同患病率与结局:来自儿童脑肿瘤图谱与儿童神经肿瘤联盟的研究

Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium.
PubMed 文献 · Neuro Oncol · 2025-01-01

研究对儿童脑肿瘤图谱与儿童神经肿瘤联盟中1452例儿童患者的配对正常与肿瘤全基因组测序进行遗传祖先预测,评估报告的种族与民族及基于祖先的遗传超级人群对肿瘤组织学、分子亚型、生存和治疗的影响,发现不同祖先超级人群在组织学、分子亚型、生存和治疗利用上存在差异。

要点

  • 报告的种族与民族和基于祖先的遗传超级人群非随机相关(P < .001)。
  • 非欧洲裔生殖细胞肿瘤患者和AMR型SHH激活髓母细胞瘤患者EFS较欧洲裔更差。
  • AMR患者临床试验入组频率更高,但光子较质子放疗使用增加。

核心结论

  • 来自PBTA和PNOC的儿童中枢神经系统肿瘤在组织学和分子亚型上存在与遗传祖先相关的差异,需要进一步研究遗传和社会经济因素对这些观察到的差异的贡献。

研究设计与样本

  • 研究对来自OpenPedCan项目的1452例儿童患者的配对正常与肿瘤全基因组测序进行遗传祖先预测,以评估报告的种族与民族及基于祖先的遗传超级人群对肿瘤组织学、分子亚型、生存和治疗的影响。

主要发现

  • 预测的超级人群包括非洲(AFR,N = 153)、混合美洲(AMR,N = 222)、东亚(EAS,N = 67)、欧洲(EUR,N = 968)和南亚(SAS,N = 42)。
  • 报告的种族与民族和基于祖先的遗传超级人群非随机相关(P < .001)。
  • 非典型畸胎样/横纹肌样瘤或脑膜瘤患者中AFR祖先富集(OR = 2.6,FDR = 0.01;OR = 2.9,FDR = 0.01)。
  • 在KIAA1549::BRAF融合阳性低级别胶质瘤(LGG)诊断中,EAS和SAS患者 disproportionately 携带外显子15:09断点(FDR < 0.05),AMR患者显示罕见断点,与其他断点相比,与较低程度的手术切除和较差的无事件生存(EFS)相关(风险比(HR)= 4.6,P = .03)。
  • 非EUR生殖细胞肿瘤患者和AMR型SHH激活髓母细胞瘤患者分别相对于EUR患者表现出较差的EFS(HR = 12.1,P < .01;HR = 5.2,P = .03),AFR LGG患者(HR = 16.4,P < .01)或室管膜瘤患者(HR = 5.5,P = .02)相对于EUR患者总生存较差。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究遗传和社会经济因素对这些观察到的差异的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Central nervous system (CNS) tumors lead to cancer-related mortality in children. Genetic ancestry-associated cancer prevalence and outcomes have been studied but are limited. METHODS: We performed genetic ancestry prediction in 1,452 pediatric patients with paired normal and tumor whole genome sequencing from the Open Pediatric Cancer (OpenPedCan) project to evaluate the influence of reported race and ethnicity and ancestry-based genetic superpopulations on tumor histology, molecular subtype, survival, and treatment. RESULTS: Predicted superpopulations included African (AFR, N = 153), Admixed American (AMR, N = 222), East Asian (EAS, N = 67), European (EUR, N = 968), and South Asian (SAS, N = 42). Reported race and ethnicity and ancestry-based genetic superpopulations were non-randomly associated (P < .001). Patients with an atypical teratoid rhabdoid tumor or meningioma were enriched for AFR ancestry (OR = 2.6, FDR = 0.01; OR = 2.9, FDR = 0.01, respectively). Among KIAA1549::BRAF fusion-positive low-grade glioma (LGG) diagnoses, EAS and SAS patients disproportionately harbored exon 15:09 breakpoints (FDR < 0.05), and AMR patients demonstrated rare breakpoints, which were associated with lesser degree of surgical resection and worse event-free survival (EFS) versus other breakpoints (hazard ratio (HR) = 4.6, P = .03). Non-EUR and AMR patients with germ cell tumors and SHH-activated medulloblastoma, respectively, exhibited worse EFS relative to EUR patients (HR = 12.1, P < .01; HR = 5.2, P = .03) and AFR patients with LGG (HR = 16.4, P < .01) or ependymoma (HR = 5.5, P = .02) had worse overall survival compared to EUR patients. We observed a higher frequency of clinical trial enrollment among AMR patients across tumor histologies (OR = 2.0, P ≤ .01), but increased utilization of photon versus proton radiation relative to other superpopulations (OR = 0.55, P= .04). CONCLUSIONS: Genetic ancestry-associated differences exist across pediatric CNS tumor histological and molecular subtypes from PBTA and PNOC. Further investigation into genetic and socioeconomic factors contributing to these observed inequities is needed.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Corbett RJ, Gullickson CC, Geng Z, et al. Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium. Neuro Oncol. 2025. PMID: 39847453. doi:10.1093/neuonc/noaf017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。